Health
Researchers discover mechanism behind severe cases of G6PD deficiency – Drug Target Review
Researchers have revealed how the most severe cases of G6PD deficiency occur, which could help scientists design new drugs for the disease.
Posted: 20 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have revealed how the most severe cases of G6PD deficiency occur, which could help scientists design new drugs for the disease.
G6PD protein
Researchers have uncovered the mechanism behind the most severe cases of glucose-6-phosphate dehydrogenase (G6PD) deficiency: a broken chain of amino acids that warps the shape of the condition’s namesake protein, G6PD. The study was conducted at the US Department of…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News10 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred